Researchers have found the injectable weight-loss treatment Ozempic could reduce the risk of heart attacks across the UK.
A study revealed semaglutide, a key ingredient in treatments including Wegovy and Ozempic could likely boost the cardiovascular health of millions.
UK correspondent Enda Brady says it's likely Ozempic will be routinely prescribed in the UK by the end of the decade.
LISTEN ABOVE

Enda Brady: UK correspondent on the additional calls for Sir Keir Starmer to resign
04:23

Paul Bloxham: HSBC Chief Economist ahead of Australia's 2026 federal budget
04:17

Jamie Mackay: The Country host on what the latest Rabobank agribusiness monthly report means for Kiwi farmers
04:46